Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.

@article{Henriksson1989EstrogeninducedGF,
  title={Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.},
  author={Peter Henriksson and Kurt Einarsson and Ambj{\"o}rn Eriksson and U Kelter and Bo Angelin},
  journal={The Journal of clinical investigation},
  year={1989},
  volume={84 3},
  pages={
          811-6
        }
}
To assess if and by which mechanisms pharmacological estrogen treatment induces gallstone disease, we examined patients with recently diagnosed prostatic cancer randomly allocated to estrogen therapy (n = 37) or orchidectomy (n = 35). According to gallbladder ultrasonography, after 1 yr new gallstones had developed in 5 of 28 estrogen-treated patients, compared with 0 of 26 orchidectomized patients (P = 0.03). Estrogen therapy for 3 mo increased the relative concentration of cholesterol and… 

Figures and Tables from this paper

Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.

It is suggested that estrogens at the doses studied could promote gallstone formation by alteration of biliary lipids and cholesterol nucleation time that have been incriminated in this process.

Effect of Estrogen plus Progestin on Risk for Biliary Tract Surgery in Postmenopausal Women with Coronary Artery Disease: The Heart and Estrogen/progestin Replacement Study

To determine whether estrogen plus progestin therapy is associated with the risk for biliary tract surgery among postmenopausal women, data were analyzed from the Heart and Estrogen/progestin Replacement Study (HERS), the first large randomized, double-blind trial of estrogenPlusProgestin therapy for the secondary prevention of coronary heart disease.

Sex-Based Differences in Pancreatic and Biliary Disease

While environmental and genetic factors influence gallstone formation, women beyond puberty are at a twoto threefold higher risk for cholelithiasis compared to men, and endogenous estrogen secretion may explain the observed gender differences in gallstone development.

Postmenopausal Hormone Replacement Therapy and the Risks of Calculous Gallbladder Disease

The long-term effects of menopause as a risk factor for osteoporosis is reviewed, and one of the documented side effects of HRT is an increased risk of calculous gallbladder disease, the subject of this review.

Drug-Induced Gallbladder Disease

A great variety of drugs is reported to induce gallbladder disease by various pathogenetic mechanisms, and some drugs, such as erythromcyin or ampicillin, are reported to cause hypersensitivityinduced cholecystitis.

Estrogen in Patients with Prostatic Cancer

SummaryEstrogen therapy of patients with prostatic carcinoma appears to be at least as effective in antitumour activity as surgical castration; the recent therapeutic alternative of gonadorelin

Is there a link between oestrogen therapy and gallbladder disease?

It is unequivocally confirmed that oral oestrogen use in postmenopausal women is causally associated with gallbladder disease, and the magnitude of the effect is not influenced greatly by the presence or absence of progestins.
...

References

SHOWING 1-10 OF 25 REFERENCES

Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma.

It is concluded that a profound increase in LDL catabolism is induced through administration of pharmacological doses of estrogen in males, and hypothesize that this is the consequence of an increased expression of hepatic LDL receptors.

Cholesterol crystals and the formation of cholesterol gallstones.

Gallbladder bile was obtained by means of duodenal intubation in 54 patients and from 17 patients undergoing cholecystectomy for cholelithiasis and cholesterol crystallization is probably a prerequisite for the formation of cholesterol gallstones; however, many subjects have no crystallization despite marked supersaturation.

Influence of age on secretion of cholesterol and synthesis of bile acids by the liver.

Cholesterol saturation of bile increases with age as a consequence of enhanced hepatic secretion of cholesterol and decreased bile acid synthesis, which may explain why age is a risk factor for the development of cholesterol gallstones.

Ethinylestradiol stimulates a biliary cholesterol‐phospholipid cosecretion mechanism in the hamster

The mechanism of ethinylestradiol‐induced biliary secretion of excess cholesterol, a potential causative factor of cholesterol gallstones, is not yet known but its effect on bile acid metabolism and on secretory relationships between taurocholate and cholesterol/phospholipids in bile are studied.

Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.

In general, patients whose gallstones dissolved ingested a higher dose of chenodeoxycholic acid or had bile that contained a higher proportion of this acid and it was more unsaturated, but there were many exceptions, casting doubt on the value of a single analysis of fasting-state bile for predicting gallstone dissolutions.

Contraceptive steroids alter the steady-state kinetics of bile acids.

The data indicate that contraceptive steroids directly alter the hepatic synthesis of bile acids and suggest that newly synthesized cholesterol may be a preferred substrate for bile acid synthesis during use of contraceptive steroids.

Biliary lipid composition during treatment with different hypolipidaemic drugs *

Abstract. In an attempt to clarify the possible lithogenic effects of commonly used hypolipidaemic drugs, gallbladder bile was obtained from patients with primary hyperlipoproteinaemia before and

Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.

In human liver a parallel stimulation of cholesterol synthesis and LDL receptor expression occurs in response to stimulation of bile acid synthesis, suggesting a simultaneous stimulatory effect to compensate for the increased hepatic cholesterol catabolism due to bile acids depletion caused by cholestyramine.